A Multinational, Observational Registry-Based Study of a Potential Link Between Finasteride and Male Breast Cancer in 4 Nordic Countries
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Male
Male Breast Cancer
Male
Male Breast Cancer
Trial Information
A Multinational, Observational Registry-Based Study of a Potential Link Between Finasteride and Male Breast Cancer in 4 Nordic Countries
Inclusion Criteria:
- Participant's study medical information available in population-based health and
medical registries, prescription registries, and mortality registries in Denmark,
Finland, Norway, or Sweden within the observation period of 1995 to 2009
- Male with breast cancer with medical information in one of the 4 country-specific
registries in this study
- Study participant's exposure to finasteride is available
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Outcome Measure:
Person-Years of Exposure to Finasteride by Participant Age and Year
Outcome Time Frame:
Up to 14 years
Safety Issue:
No
Authority:
Denmark: Danish Health and Medicines Authority
Study ID:
0906-162
NCT ID:
NCT01703520
Start Date:
May 2011
Completion Date:
March 2015
Related Keywords:
- Male Breast Cancer
- Males breast cancer
- Finasteride
- PROSCAR®
- PROPECIA®
- Breast Neoplasms
- Breast Neoplasms, Male
Name | Location |
|---|
